The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports

$ADI, $AAPL, $BMRN, $GLW, $EA, $MCHP

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers.

Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of stocks analysts have singled out to look at carefully Thursday, as follows:

Analog Devices Inc. (NASDAQ:ADI) was raised to Outperform from Market Perform with a 120 target price at Raymond James.

Apple Inc. (NASDAQ:AAPL) was reiterated as Outperform with the same 265 price target at Wedbush, but that target was raised recently. The firm’s note sees Apple reaching the 100-M subscriber number over 4 years and it could translate into a $7 to 10-B annual revenue stream over time that also further cements its install base and halo effect that could add in another 15 per share to the sum-of-the-parts valuation.

Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) was maintained as Buy but the target price was lowered to 95 from 120 at Citigroup.

Corning Inc. (NYSE:GLW) was reiterated as Buy and the price target was raised to 34 from 32 at Citigroup. Deutsche Bank downgraded it to Hold from Buy and lowered its target to 30 from 33.

Electronic Arts Inc. (NASDAQ:EA) Wedbush reiterated its Outperform rating with a 118 target price, while UBS maintained its Buy rating but trimmed its target price to 117 from 120.

Microchip Technology Inc. (NASDAQ:MCHP) was raised to Strong Buy from Outperform with a 115 target price at Raymond James.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH